159 related articles for article (PubMed ID: 31119098)
1. Identification of
Zhao X; Xu M; Cai Z; Yuan W; Cui W; Li MD
Front Oncol; 2019; 9():325. PubMed ID: 31119098
[No Abstract] [Full Text] [Related]
2. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
3. Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma.
Yang C; Chen J; Yu Z; Luo J; Li X; Zhou B; Jiang N
Front Oncol; 2021; 11():621806. PubMed ID: 33718182
[TBL] [Abstract][Full Text] [Related]
4. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
5. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.
Gu X; Li B; Jiang M; Fang M; Ji J; Wang A; Wang M; Jiang X; Gao C
Oncotarget; 2015 Aug; 6(24):20661-71. PubMed ID: 25970782
[TBL] [Abstract][Full Text] [Related]
8. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
9. Identification of IFN-Induced Transmembrane Protein 1 With Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis.
Wu L; Zhu X; Yan D; Tang M; Ma C; Yan S
Front Oncol; 2021; 11():626883. PubMed ID: 33869009
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG.
Duan S; Gong B; Wang P; Huang H; Luo L; Liu F
Mol Med Rep; 2018 Oct; 18(4):3727-3736. PubMed ID: 30106150
[TBL] [Abstract][Full Text] [Related]
14. Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma.
Xu WH; Wu J; Wang J; Wan FN; Wang HK; Cao DL; Qu YY; Zhang HL; Ye DW
Front Genet; 2019; 10():821. PubMed ID: 31572440
[No Abstract] [Full Text] [Related]
15. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract][Full Text] [Related]
16. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
17. Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis.
Wang J; Liu H; Shen X; Wang Y; Zhang D; Shen S; Suo T; Pan H; Ming Y; Ding K; Liu H
Oncol Lett; 2017 May; 13(5):3508-3516. PubMed ID: 28529578
[TBL] [Abstract][Full Text] [Related]
18. Network-Based Meta-Analyses of Associations of Multiple Gene Expression Profiles with Bone Mineral Density Variations in Women.
He H; Cao S; Niu T; Zhou Y; Zhang L; Zeng Y; Zhu W; Wang YP; Deng HW
PLoS One; 2016; 11(1):e0147475. PubMed ID: 26808152
[TBL] [Abstract][Full Text] [Related]
19. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer.
Zhu X; Li T; Niu X; Chen L; Ge C
Oncol Lett; 2020 Oct; 20(4):44. PubMed ID: 32802166
[TBL] [Abstract][Full Text] [Related]
20. LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Luo Q; Wang C; Jin G; Gu D; Wang N; Song J; Jin H; Hu F; Zhang Y; Ge T; Huo X; Chu W; Shu H; Fang J; Yao M; Gu J; Cong W; Qin W
Carcinogenesis; 2015 Oct; 36(10):1201-12. PubMed ID: 26249360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
